Selank
Selank is a calming compound that helps ease stress and improve focus. It is designed to help the mind feel balanced and clear without causing drowsiness. People study it for how it may support relaxation, steady mood, and mental recovery after fatigue or tension.
Description
- Selank is a synthetic peptide analog of the natural immunomodulatory fragment tuftsin.
- Developed in Russia for its anti-anxiety, nootropic, and neuroprotective effects.
- Studied for regulating stress response, cognitive performance, and immune balance.
How It Works
- Modulates serotonin, dopamine, and GABA neurotransmission for calmness and focus.
- Influences immune and neuroendocrine signaling to reduce anxiety and fatigue.
- Supports synaptic plasticity and neuronal stability through neurotrophic regulation.
Documented Effects
- Reduces symptoms of anxiety and emotional tension without sedation or addiction risk.
- Improves focus, learning, and cognitive clarity during stress or fatigue.
- Supports recovery from mental exhaustion and stress-related imbalance.
- Enhances immune modulation and overall stress resilience in clinical trials.
- May stabilize mood through regulation of central nervous system peptides.
Theoretical Effects
- Potential neuroprotective and antioxidant actions on brain cells (preclinical data).
- May improve mitochondrial stability and reduce neuroinflammation.
- Broader metabolic and hormonal effects remain unconfirmed in humans.
Pharmacokinetics
- Half-life: approximately 2–10 minutes after injection, with rapid receptor binding.
- Time to peak concentration: within 5–15 minutes post-administration.
- Steady-state: achieved after several consecutive daily doses due to cumulative receptor modulation.
Duration of Effects
- Mental calming and focus-enhancing effects typically last 4–6 hours per dose.
- Residual mood stability may persist up to 24 hours with consistent daily use.
- Effects taper gradually after discontinuation without rebound anxiety.
Reconstitution
- Use only bacteriostatic water to reconstitute the lyophilized powder.
- Example vial: 5 mg of Selank
- Choose reconstitution volume based on dosing convenience:
- 1 mL water → 0.5 mg (500 mcg) per 10 units
- 2 mL water → 0.25 mg (250 mcg) per 10 units
- Swirl gently to dissolve; avoid shaking.
- Refrigerate reconstituted solution (2–8 °C). Use within ~25 days for best stability.
Selank – Injectable Dosage Overview (First-Time Use)
Typical Starting Dose
- Injectable (off-label, anecdotal): ~200–500 mcg subcutaneous (SC) once daily.
- Conservative entry point: start at ~200 mcg SC to assess tolerance.
Common Therapeutic Range
- Injectable reports: 200–500 mcg SC daily → up to ~1 mg/day in intensive protocols.
- Used primarily for anxiety reduction, stress modulation, and cognitive steadiness.
Maximum Daily Dose
- Anecdotal ceiling: ~1 mg/day SC.
- Higher doses (>1 mg/day) lack human data and show no added benefit.
Standard Cycle Length
- Light use: 5–10 days, then reassess or taper.
- Therapeutic use: up to 30 days continuous → followed by at least 2–4 weeks off before repeating.
Clinical Notes
- Typically administered via subcutaneous injection or nasal spray in research settings.
- No tapering required; discontinuation does not cause rebound effects.
- Should not be stacked with strong sedatives or GABAergic agents to avoid overlap.
- Stable for about 25 days when refrigerated (2–8°C). Protect from light and heat. Avoid freezing.
Safety Notes (First-Time Use)
- Begin low (~200 mcg SC) and increase only if tolerated.
- Possible effects: relaxation, improved clarity, mild fatigue, or transient sleep changes.
- Maintain sterile technique during injections to prevent contamination.
- Ensure product purity and proper cold storage (2–8°C after reconstitution).
- Human long-term safety data remain limited; research use only.
Disclaimer:
This information is provided for research and educational purposes only. It does not constitute medical advice, diagnosis, or treatment guidance. Always consult a qualified healthcare professional before making medical or health decisions.